NextGen Healthcare
Market Cap
US$997.2m
Last Updated
2021/09/22 00:10 UTC
Data Sources
Company Financials +
Executive Summary
NextGen Healthcare, Inc. provides software and services for ambulatory healthcare services in the United States. More Details
Rewards
Risk Analysis
Snowflake Analysis
Flawless balance sheet and good value.
Similar Companies
Share Price & News
How has NextGen Healthcare's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: NXGN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: NXGN's weekly volatility (4%) has been stable over the past year.
Market Performance
7 Day Return
0.3%
NXGN
-0.5%
US Healthcare Services
-1.8%
US Market
1 Year Return
20.7%
NXGN
5.9%
US Healthcare Services
31.5%
US Market
Return vs Industry: NXGN exceeded the US Healthcare Services industry which returned 6.8% over the past year.
Return vs Market: NXGN underperformed the US Market which returned 33% over the past year.
Shareholder returns
| NXGN | Industry | Market | |
|---|---|---|---|
| 7 Day | 0.3% | -0.5% | -1.8% |
| 30 Day | -1.3% | 2.5% | -0.9% |
| 90 Day | -10.3% | -2.8% | 0.8% |
| 1 Year | 20.7%20.7% | 6.0%5.9% | 33.5%31.5% |
| 3 Year | -27.3%-27.3% | 84.5%83.2% | 57.5%47.8% |
| 5 Year | 31.4%31.4% | 191.0%187.2% | 119.1%95.3% |
Long-Term Price Volatility Vs. Market
How volatile is NextGen Healthcare's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall St
Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 44% Undervaluation?3 months ago | Simply Wall St
How Much Are NextGen Healthcare, Inc. (NASDAQ:NXGN) Insiders Taking Off The Table?3 months ago | Simply Wall St
The Returns On Capital At NextGen Healthcare (NASDAQ:NXGN) Don't Inspire ConfidenceValuation
Is NextGen Healthcare undervalued compared to its fair value and its price relative to the market?
49.7%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: NXGN ($14.81) is trading below our estimate of fair value ($29.44)
Significantly Below Fair Value: NXGN is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: NXGN is good value based on its PE Ratio (75.6x) compared to the US Healthcare Services industry average (107.5x).
PE vs Market: NXGN is poor value based on its PE Ratio (75.6x) compared to the US market (17.5x).
Price to Earnings Growth Ratio
PEG Ratio: NXGN is poor value based on its PEG Ratio (1.8x)
Price to Book Ratio
PB vs Industry: NXGN is good value based on its PB Ratio (2.3x) compared to the US Healthcare Services industry average (6.3x).
Future Growth
How is NextGen Healthcare forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?
41.4%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NXGN's forecast earnings growth (41.4% per year) is above the savings rate (2%).
Earnings vs Market: NXGN's earnings (41.4% per year) are forecast to grow faster than the US market (14.9% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: NXGN's revenue (6.3% per year) is forecast to grow slower than the US market (9.8% per year).
High Growth Revenue: NXGN's revenue (6.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NXGN's Return on Equity is forecast to be low in 3 years time (1.9%).
Past Performance
How has NextGen Healthcare performed over the past 5 years?
8.1%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NXGN has a large one-off loss of $5.1M impacting its June 30 2021 financial results.
Growing Profit Margin: NXGN's current net profit margins (2.3%) are higher than last year (1%).
Past Earnings Growth Analysis
Earnings Trend: NXGN has become profitable over the past 5 years, growing earnings by 8.1% per year.
Accelerating Growth: NXGN's earnings growth over the past year (142.9%) exceeds its 5-year average (8.1% per year).
Earnings vs Industry: NXGN earnings growth over the past year (142.9%) exceeded the Healthcare Services industry 32.4%.
Return on Equity
High ROE: NXGN's Return on Equity (3%) is considered low.
Financial Health
How is NextGen Healthcare's financial position?
Financial Position Analysis
Short Term Liabilities: NXGN's short term assets ($194.2M) exceed its short term liabilities ($155.1M).
Long Term Liabilities: NXGN's short term assets ($194.2M) exceed its long term liabilities ($30.9M).
Debt to Equity History and Analysis
Debt Level: NXGN is debt free.
Reducing Debt: NXGN has no debt compared to 5 years ago when its debt to equity ratio was 32.4%.
Debt Coverage: NXGN has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: NXGN has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Dividend
What is NextGen Healthcare current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate NXGN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NXGN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if NXGN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NXGN's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: NXGN is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of NXGN's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
3.6yrs
Average management tenure
CEO
Jamie Arnold (65 yo)
0.17
Tenure
US$3,303,295
Compensation
Mr. James Robert Arnold, Jr. also known as Jamie, serves as Interim Principal Executive Officer at NextGen Healthcare, Inc. since July 28, 2021. He has been Chief Financial Officer and Executive Vice Presi...
CEO Compensation Analysis
Compensation vs Market: Jamie's total compensation ($USD3.30M) is above average for companies of similar size in the US market ($USD2.34M).
Compensation vs Earnings: Jamie's compensation has increased by more than 20% in the past year.
Leadership Team
Experienced Management: NXGN's management team is considered experienced (3.6 years average tenure).
Board Members
Experienced Board: NXGN's board of directors are considered experienced (5.8 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
NextGen Healthcare, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: NextGen Healthcare, Inc.
- Ticker: NXGN
- Exchange: NasdaqGS
- Founded: 1974
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: US$997.189m
- Shares outstanding: 67.33m
- Website: https://www.nextgen.com
Number of Employees
Location
- NextGen Healthcare, Inc.
- 3525 Piedmont Road
- NE Building 6
- Atlanta
- Georgia
- 30305
- United States
Listings
Biography
NextGen Healthcare, Inc. provides software and services for ambulatory healthcare services in the United States. The company offers patient engagement solutions, comprising of NextGen PxP Portal, NextGen P...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/09/22 00:10 |
| End of Day Share Price | 2021/09/21 00:00 |
| Earnings | 2021/06/30 |
| Annual Earnings | 2021/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.